ATPBOT Launches The ChatGPT of Quantitative Trading 8-03-2023, 10:00

New Jersey Institute of Technology Appoints Ed Wozencroft 10-03-2023, 03:21

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed 21-09-2025, 09:15